Tritan Renew, which is made with 50% certified recycled content derived from hard-to-recycle waste, performs like virgin-quality material
Collaboration streamlines patient access to oncology clinical trials
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Collaboration provides AstraZeneca with exclusive rights to Omniose’s proprietary bioconjugation platform to explore potential vaccines for a broad range of bacterial pathogens
Innovent will supply sintilimab for the collaborated clinical trial
Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
The LyondellBasell CirculenRenew polymers are made from renewable feedstocks derived from bio-based wastes
Phase 3 data expected in the second half of 2024
The collaboration brings a seamless digital experience to more formulators worldwide
Subscribe To Our Newsletter & Stay Updated
